These findings are consistent with previous reports in prostate cancer [15], where similar PLK1-mediated regulation of the CRAF-MEK-ERK axis has been demonstrated, further supporting PLK1′s role in modulating key oncogenic pathways across different cancer types. This evidence concerns the gene RAF1 and prostate carcinoma.